I came across the following article in The Guardian UK newspaper this morning. Ena Respiratory is certainly managing to generate international exposure in the media over their proposed nasal spray. Have not been able to find any reference in the international mainstream media re SPL's SPL7013 nasal spray.
SPL are in a rather unique position and should be first to market which will benefit all SH's, however the great beneficiaries will be the frontline health workers, teachers, retail workers, the vulnerable, and anyone who has regular contact with other people. The current sense of urgency and focus is clearly evident, looking forward to further developments/announcements from SPL.
SPL Price at posting:
$1.61 Sentiment: Buy Disclosure: Held
